Bio Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Bio Techne Corp
TECH Stock  USD 77.42  0.21  0.27%   
Bio Techne financial statements provide useful quarterly and yearly information to potential Bio Techne Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bio Techne financial statements helps investors assess Bio Techne's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bio Techne's valuation are summarized below:
Gross Profit
770.2 M
Profit Margin
0.145
Market Capitalization
12.3 B
Enterprise Value Revenue
10.8269
Revenue
1.2 B
We have found one hundred twenty available fundamental signals for Bio Techne Corp, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Bio Techne Corp prevailing fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year. The Bio Techne's current Market Cap is estimated to increase to about 2.4 B. The Bio Techne's current Enterprise Value is estimated to increase to about 2.3 B

Bio Techne Total Revenue

1.22 Billion

Check Bio Techne financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Techne's main balance sheet or income statement drivers, such as Depreciation And Amortization of 117.3 M, Total Revenue of 1.2 B or Gross Profit of 811.7 M, as well as many indicators such as Price To Sales Ratio of 6.9, Dividend Yield of 0.0042 or PTB Ratio of 6.78. Bio financial statements analysis is a perfect complement when working with Bio Techne Valuation or Volatility modules.
  
Check out the analysis of Bio Techne Correlation against competitors.

Bio Techne Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3 B2.8 B1.6 B
Slightly volatile
Short and Long Term Debt Total440.5 M419.5 M265.8 M
Slightly volatile
Total Current Liabilities167.3 M159.4 M93.1 M
Slightly volatile
Total Stockholder Equity2.2 B2.1 B1.2 B
Slightly volatile
Property Plant And Equipment Net359.6 M342.4 M190.8 M
Slightly volatile
Retained Earnings1.4 B1.3 B876.4 M
Slightly volatile
Cash89.5 M151.8 M131.6 M
Pretty Stable
Non Current Assets Total2.3 B2.2 B1.2 B
Slightly volatile
Cash And Short Term Investments137.1 M152.9 M194.8 M
Very volatile
Net Receivables253.5 M241.4 M122.8 M
Slightly volatile
Common Stock Shares Outstanding169.2 M160.8 M153.4 M
Slightly volatile
Liabilities And Stockholders Equity3 B2.8 B1.6 B
Slightly volatile
Non Current Liabilities Total614.2 M585 M346.3 M
Slightly volatile
Inventory188.7 M179.7 M90.5 M
Slightly volatile
Other Current Assets45.6 M43.4 M16.4 M
Slightly volatile
Other Stockholder Equity861.4 M820.3 M369.3 M
Slightly volatile
Total Liabilities781.6 M744.3 M439.4 M
Slightly volatile
Total Current Assets648.3 M617.4 M427.6 M
Slightly volatile
Short Term Debt7.6 M12.9 M10.4 M
Slightly volatile
Accounts Payable23.7 M38 M47.3 M
Slightly volatile
Intangible Assets532.4 M507.1 M367.8 M
Slightly volatile
Property Plant And Equipment Gross628.9 M599 M226.1 M
Slightly volatile
Common Stock Total Equity1.9 M1.8 M642.4 K
Slightly volatile
Short Term Investments1 M1.1 M61.2 M
Slightly volatile
Common Stock1.7 M1.6 M610.9 K
Slightly volatile
Other Liabilities97.2 M114.9 M89.1 M
Slightly volatile
Property Plant Equipment139.9 M260.1 M167.2 M
Slightly volatile
Good Will1 B972.7 M555 M
Slightly volatile
Capital Surpluse871.3 M829.8 M379.4 M
Slightly volatile
Short and Long Term Debt13.7 M14.4 M33 M
Very volatile
Non Current Liabilities Other14.1 M13.2 M16.9 M
Very volatile
Long Term Debt Total318.6 M402.5 M241.3 M
Slightly volatile
Net Invested Capital2.5 B2.4 B1.3 B
Pretty Stable
Net Working Capital411.8 M458 M312.1 M
Slightly volatile
Capital Stock862.4 K1.6 M573.2 K
Slightly volatile
Capital Lease Obligations94.9 M100.5 M81.2 M
Slightly volatile

Bio Techne Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization117.3 M111.7 M62.3 M
Slightly volatile
Total Revenue1.2 B1.2 B677 M
Slightly volatile
Gross Profit811.7 M773.1 M458.4 M
Slightly volatile
Other Operating Expenses951.3 M906 M497.5 M
Slightly volatile
Operating Income265.7 M253 M167 M
Slightly volatile
EBIT265.7 M253 M163.2 M
Slightly volatile
EBITDA383 M364.8 M225.5 M
Slightly volatile
Cost Of Revenue405.3 M386 M218.6 M
Slightly volatile
Total Operating Expenses546 M520 M278.9 M
Slightly volatile
Income Before Tax114.4 M185.7 M166.8 M
Slightly volatile
Net Income87.3 M168.1 M135.3 M
Slightly volatile
Income Tax Expense27.4 M17.6 M32.2 M
Pretty Stable
Research Development101.5 M96.7 M57.7 M
Slightly volatile
Selling General Administrative416.7 M396.8 M205.6 M
Slightly volatile
Net Income Applicable To Common Shares344.5 M328.1 M164.8 M
Slightly volatile
Net Income From Continuing Ops160.6 M168.1 M147 M
Slightly volatile
Interest Income3.5 M3.3 M3.7 M
Slightly volatile
Selling And Marketing Expenses24.5 M26.5 M36.1 M
Slightly volatile
Reconciled Depreciation95.3 M111.7 M76.6 M
Slightly volatile
Extraordinary Items26.6 M29.9 M32.5 M
Slightly volatile

Bio Techne Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow247.9 M236.1 M164.5 M
Slightly volatile
Begin Period Cash Flow189.6 M180.6 M133.3 M
Slightly volatile
Depreciation117.3 M111.7 M62.3 M
Slightly volatile
Capital Expenditures66 M62.9 M29.9 M
Slightly volatile
Total Cash From Operating Activities313.9 M299 M194.5 M
Slightly volatile
Net Income89.4 M168.1 M134.8 M
Slightly volatile
End Period Cash Flow91.7 M151.8 M131.7 M
Pretty Stable
Stock Based Compensation39.9 M38 M22.6 M
Slightly volatile
Dividends Paid49.8 M50.4 M46.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio6.99.74369.5961
Slightly volatile
Dividend Yield0.00420.00450.0087
Slightly volatile
PTB Ratio6.785.45885.7304
Slightly volatile
Days Sales Outstanding45.7476.017561.649
Pretty Stable
Book Value Per Share13.7713.11827.8202
Slightly volatile
Free Cash Flow Yield0.0320.02090.0276
Slightly volatile
Operating Cash Flow Per Share1.991.89581.2687
Slightly volatile
Average Payables3.9 M3.8 M3.4 M
Pretty Stable
Stock Based Compensation To Revenue0.01920.03280.0263
Slightly volatile
Capex To Depreciation0.530.56290.6144
Slightly volatile
PB Ratio6.785.45885.7304
Slightly volatile
EV To Sales6.829.97469.6635
Slightly volatile
Free Cash Flow Per Share1.571.49711.074
Slightly volatile
ROIC0.180.09540.1075
Pretty Stable
Inventory Turnover2.042.14762.5813
Slightly volatile
Net Income Per Share1.121.06590.9226
Slightly volatile
Days Of Inventory On Hand85.46170139
Very volatile
Payables Turnover9.4110.16616.389
Slightly volatile
Sales General And Administrative To Revenue0.360.34240.2772
Slightly volatile
Average Inventory4.4 M5.6 M6 M
Pretty Stable
Research And Ddevelopement To Revenue0.120.08340.0939
Slightly volatile
Capex To Revenue0.0710.05420.043
Slightly volatile
Cash Per Share0.650.96931.2714
Pretty Stable
POCF Ratio23.637.773233.4382
Slightly volatile
Payout Ratio0.40.29990.3631
Slightly volatile
Capex To Operating Cash Flow0.280.21030.1653
Pretty Stable
PFCF Ratio46.5147.832641.1488
Slightly volatile
Days Payables Outstanding43.7935.903776.259
Slightly volatile
Income Quality1.041.77891.3813
Pretty Stable
ROE0.07720.08130.1222
Slightly volatile
EV To Operating Cash Flow23.3738.668733.8252
Slightly volatile
PE Ratio70.5467.18150.8066
Slightly volatile
Return On Tangible Assets0.160.12610.1989
Pretty Stable
EV To Free Cash Flow33.6248.966640.7759
Slightly volatile
Earnings Yield0.01410.01490.0243
Slightly volatile
Intangibles To Total Assets0.550.5260.5039
Slightly volatile
Current Ratio3.683.87395.9794
Slightly volatile
Receivables Turnover7.214.80156.0728
Slightly volatile
Graham Number18.6217.737512.6102
Slightly volatile
Shareholders Equity Per Share13.7713.11827.8202
Slightly volatile
Debt To Equity0.140.16040.1974
Slightly volatile
Capex Per Share0.420.39870.1946
Slightly volatile
Average Receivables16.3 M18.8 M20.3 M
Slightly volatile
Revenue Per Share7.727.34944.4093
Slightly volatile
Interest Debt Per Share2.312.20441.6996
Slightly volatile
Debt To Assets0.0960.1180.134
Slightly volatile
Enterprise Value Over EBITDA19.4231.695434.0946
Slightly volatile
Short Term Coverage Ratios34.3423.140921.3393
Very volatile
Price Earnings Ratio70.5467.18150.8066
Slightly volatile
Operating Cycle131246201
Pretty Stable
Price Book Value Ratio6.785.45885.7304
Slightly volatile
Days Of Payables Outstanding43.7935.903776.259
Slightly volatile
Dividend Payout Ratio0.40.29990.3631
Slightly volatile
Price To Operating Cash Flows Ratio23.637.773233.4382
Slightly volatile
Price To Free Cash Flows Ratio46.5147.832641.1488
Slightly volatile
Pretax Profit Margin0.270.16020.2838
Slightly volatile
Ebt Per Ebit0.850.73381.1422
Very volatile
Operating Profit Margin0.260.21830.269
Slightly volatile
Effective Tax Rate0.090.09470.2005
Slightly volatile
Company Equity Multiplier1.391.35981.3862
Very volatile
Long Term Debt To Capitalization0.10.13360.1474
Slightly volatile
Total Debt To Capitalization0.110.13830.155
Slightly volatile
Return On Capital Employed0.09060.09540.1249
Slightly volatile
Debt Equity Ratio0.140.16040.1974
Slightly volatile
Ebit Per Revenue0.260.21830.269
Slightly volatile
Quick Ratio2.612.74624.9616
Slightly volatile
Net Income Per E B T0.580.90530.7798
Slightly volatile
Cash Ratio0.90.95242.244
Slightly volatile
Cash Conversion Cycle221210136
Very volatile
Operating Cash Flow Sales Ratio0.240.2580.2864
Pretty Stable
Days Of Inventory Outstanding85.46170139
Very volatile
Days Of Sales Outstanding45.7476.017561.649
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.60.78970.8267
Pretty Stable
Cash Flow Coverage Ratios0.860.90082.8071
Slightly volatile
Price To Book Ratio6.785.45885.7304
Slightly volatile
Fixed Asset Turnover5.423.38474.6679
Slightly volatile
Price Cash Flow Ratio23.637.773233.4382
Slightly volatile
Enterprise Value Multiple19.4231.695434.0946
Slightly volatile
Debt Ratio0.0960.1180.134
Slightly volatile
Cash Flow To Debt Ratio0.860.90082.8071
Slightly volatile
Price Sales Ratio6.99.74369.5961
Slightly volatile
Return On Assets0.05680.05980.0924
Slightly volatile
Asset Turnover0.390.4120.5201
Slightly volatile
Net Profit Margin0.190.1450.218
Pretty Stable
Gross Profit Margin0.560.6670.6657
Pretty Stable
Price Fair Value6.785.45885.7304
Slightly volatile
Return On Equity0.07720.08130.1222
Slightly volatile

Bio Techne Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.4 B2.3 B2.4 B
Slightly volatile
Enterprise Value2.3 B2.2 B2.2 B
Slightly volatile

Bio Fundamental Market Drivers

Forward Price Earnings40.8163
Cash And Short Term Investments152.9 M

Bio Upcoming Events

1st of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of August 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

About Bio Techne Financial Statements

Investors use fundamental indicators, such as Bio Techne's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bio Techne's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue27.9 M29.3 M
Total Revenue1.2 B1.2 B
Cost Of Revenue386 M405.3 M
Stock Based Compensation To Revenue 0.03  0.02 
Sales General And Administrative To Revenue 0.34  0.36 
Research And Ddevelopement To Revenue 0.08  0.12 
Capex To Revenue 0.05  0.07 
Revenue Per Share 7.35  7.72 
Ebit Per Revenue 0.22  0.26 

Currently Active Assets on Macroaxis

GMGeneral Motors
GMGeneral Motors
GOOGAlphabet Inc Class C
SSentinelOne
VVisa Class A

Additional Information and Resources on Investing in Bio Stock

When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:
How To Invest In Bio
Details
Is Bio Stock a good investment?
Details
What is Bio Techne's Net Worth?
Details
Largest Life Sciences Tools & Services Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Bio Techne Correlation against competitors.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.44)
Dividend Share
0.32
Earnings Share
1.05
Revenue Per Share
7.349
Quarterly Revenue Growth
0.016
The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY